...
首页> 外文期刊>BMC Anesthesiology >Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma: two cases report and anesthesia considerations
【24h】

Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma: two cases report and anesthesia considerations

机译:抗N-甲基-D-天冬氨酸受体脑炎与卵巢畸胎瘤相关:2例报告和麻醉注意事项

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an immune-mediated syndrome caused by the production of anti-NMDAR receptor antibodies. The syndrome characterised by psychosis, seizures, sleep disorders, hallucinations and short-term memory loss. Ovarian teratoma is the confirmed tumour associated with anti-NMDAR antibodies. The patients with anti-NMDAR encephalitis complicated by ovarian teratoma require surgical treatment under general anesthesia. NMDARs are important targets of many anesthetic drugs. The perioperative management and complications of anti-NMDAR encephalitis, including hypoventilation, paroxysmal sympathetic hyperactivity (PSH) and epilepsy, are challenging for ansthesiologists. Case presentation This report described two female patients who presented for resection of the ovarian teratoma, they had confirmed anti-NMDAR encephalitis accompanied by ovarian teratoma. Two patients received gamma globulin treatments and the resection of the ovarian teratoma under total intravenous anesthesia. They were recovered and discharged on the 20 th and 46 th postoperative day respectively. Conclusions There is insufficient evidence about the perioperative management, monitoring and anesthesia management of anti-NMDAR encephalitis. This report was based on the consideration that controversial anesthetics that likely act on NMDARs should be avoided. Additionally, BIS monitoring should to be prudently applied in anti-NMDAR encephalitis because of abnormal electric encephalography (EEG). Anesthesiologists must be careful with regard to central ventilation dysfunctions and PSH due to anti-NMDAR encephalitis.
机译:背景技术抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎是由抗NMDAR受体抗体产生引起的免疫介导综合症。该综合征以精神病,癫痫发作,睡眠障碍,幻觉和短期记忆丧失为特征。卵巢畸胎瘤是已确认的与抗NMDAR抗体相关的肿瘤。抗NMDAR脑炎并发卵巢畸胎瘤的患者需要在全身麻醉下进行手术治疗。 NMDAR是许多麻醉药物的重要靶标。抗NMDAR脑炎的围手术期管理和并发症,包括通气不足,阵发性交感神经过度活跃症(PSH)和癫痫病,对麻醉医师而言是具有挑战性的。病例介绍该报告描述了两名女性患者,他们打算切除卵巢畸胎瘤,他们已确认伴有卵巢畸胎瘤的抗NMDAR脑炎。两名患者在全静脉麻醉下接受了γ球蛋白治疗并切除了卵巢畸胎瘤。他们分别在术后第20天和第46天恢复和出院。结论抗NMDAR脑炎的围手术期管理,监测和麻醉管理的证据不足。该报告基于以下考虑:应避免可能对NMDAR起作用的有争议的麻醉药。此外,由于异常的脑电图(EEG),应谨慎地将BIS监测用于抗NMDAR脑炎。麻醉师必须注意因抗NMDAR脑炎引起的中央通气功能障碍和PSH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号